CLO22-067: Symptom Burden in Patients With Myelofibrosis who Have Moderate or Severe Thrombocytopenia: A Retrospective Analysis of Patients Enrolled in the PERSIST-2 Study
Year: 2022
Type: article
Institutions: Mays Cancer Center at UT Health San Antonio, Mayo Clinic, Mayo Clinic in Arizona, The University of Texas MD Anderson Cancer Center, Washington University in St. Louis, Memorial Sloan Kettering Cancer Center, CTI BioPharma (United States), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4221023358
